Clinical nursing specialist
Julie Hansen
Department of Dermatology and Allergy Centre, Odense University Hospital
Projekt styring | ||
Projekt status | Active | |
Data indsamlingsdatoer | ||
Start | 01.01.2017 | |
Slut | 31.12.2018 | |
This is a clinical longitudinal study, performed in individuals with hyperhidrosis. The objective of the study is to conduct a descriptive analysis of a hyperhidrosis cohort, to explore the impact of hyperhidrosis and whether patient-reported measures of QoL will improve after treatment. With the use of three validated questionnaires, this project will clarify previously unknown knowledge about Danish patients with hyperhidrosis and more specifically contribute to the knowledge about patient-reported outcome after treatment, at the Department of Dermatology OUH.
Hyperhidrosis is a disorder characterized as perspiration in excess of the body's physiologic need. Prevalence rates of hyperhidrosis are not available in Denmark, however estimated rates in Germany (4.6%), the US (4.8%), and Sweden (5.5%) indicate that the disorder is fairly common within western countries. In recent years our department has experienced a fourfold increase in patients diagnosed with hyperhidrosis. Meanwhile existing knowledge about the population is sparse. We are initiating this study to shed light on a disorder not fully understood, with the purpose to increase quality of clinical practice and patient satisfaction.
Recruitment will take place at the Department of Dermatology in Odense University Hospital. Within a one year period we are expecting to enroll 200 newly referred patients who will be followed until one of the following events occur: patient is withdrawn from treatment or patient is placed on maintenance treatment.
Inclusion criteria:
Exclusion criteria:
At baseline visit following data will be gathered:
Demographic data: age, gender, marital status, educational level, occupation
Clinical data: site of hyperhidrosis, age of onset, family predisposition, previous surgery
In contribution validated questionnaires will be applied to measure disease severity and disease specific QoL.
At follow-up visits measures will be repeated to associate scores before and after treatment.
Department of Dermatology and Allergy Centre I, Odense University Hospital